Bladder Pain Lawsuit


Medication Lawsuits and Settlements

Victims have suffered maculopathy or other serious eye damage.
Elmiron Bladder Pain Lawsuit

BLADDER PAIN LAWSUIT INFORMATION

*An FDA approved oral medication designed to treat bladder pain is associated with interstitial cystitis (IC), a condition that affects millions of Americans each year. A study published in October 2019 by the American Academy of Ophthalmology links this bladder pain drug to toxic retina eye issues.

If you or a loved one developed vision problems after taking a brand name drug for bladder pain , you could be owed money if you suffered complications as a result.

Signs & Symptoms:

 
  • Blurred vision
  • Degenerative maculopathy
  • Difficulty adjusting to darkness
  • Eye pain
  • Halo vision
  • Macular retinopathy
  • Vision loss
  • And more…
Elmiron Eye Class

 

If you were prescribed a bladder pain drug and developed vision problems after taking the drug, you may be entitled to significant financial compensation!

Do not stop taking your medication without first consulting with your physician. Doing so could result in injury or death.

If you or a loved one used bladder pain drug and complications as a result, you could be owed money.

CALL NOW FOR A FREE CLAIM REVIEW at (800) 203-5107

Don’t wait, call now! You may be entitled to the financial compensation you deserve.

Elmiron Bladder Pain Lawsuit

 

WHAT IS A Bladder Pain Drug:

Bladder pain drugs are a commonly prescribed weak blood thinner (anti-coagulant) that is used to treat bladder pain or discomfort caused by cystitis of the bladder. Containing the active ingredient pentosan polysulfate sodium (PPS). Approved by the U.S. Food and Drug Administration (FDA) in 1996, there is a bladder pain drug on the market that is the only FDA approved oral medication designed to treat bladder pain and discomfort associated with interstitial cystitis (IC), a condition that affects millions of Americans each year. IC is more prevalent in women, and many use this brand name drug long-term to treat the disease. This bladder pain drug sales amount to at least $150 Million per year.

**In November 2018, the American Academy of Ophthalmology released a study that found a connection between long-term use of this bladder pain drug and vision problems. Another bladder pain drug study released in May 2019 concluded that this brand name bladder pain drug resulted in “potentially avoidable retinal degeneration phenomenon associated with chronic exposure.” Then the American Academy of Ophthalmology published another study in October 2019, which found that this bladder pain drug (pentosan polysuflate sodium) “appears to be toxic to the retina” and that about one-quarter of users may suffer from a form of macular degeneration or “Maculopathy.” Maculopathy is any disease that impacts the macula, which is the central part of the retina that is responsible for all central vision, most color vision, and fine detail. The type of maculopathy linked to this bladder pain drug is called pigmentary maculopathy, which according to studies, seems to be unique to users of this bladder pain drug. If caught in its early stages, the damage may stop after taking medication but in late stages, the disease can lead to permanent vision loss. So far researchers have reported on one patient whose eye damage continued for years even after stopping use of this bladder pain drug.

Sources

*Drug Watch Bladder Pain Lawsuit

**Bladder Pain Findings from Ophthalmologists

Do not stop taking your medication without first consulting with your physician. Doing so could result in injury or death.